MedPath

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

Not Applicable
Completed
Conditions
ColoRectal Cancer
Human Papillomavirus
Human Immunodeficiency Virus
Hepatitis C
Interventions
Device: OraQuick Swab
Other: Standard Screening Tests
Device: Fecal Immunochemical Test
Device: OraQuick Fingerstick
Device: HPV Self-Sampling Test
Other: Home Based Screening Tests
Registration Number
NCT02970136
Lead Sponsor
University of Miami
Brief Summary

The purpose of this research study is to determine the best way to increase screening for cervical cancer, colorectal cancer, HIV, and Hepatitis C among under screened Hispanic, Haitian and African-American individuals in Hialeah, South Dade, and Little Haiti. The investigator will compare home testing led by a community health worker (CHW) versus clinic testing guided by a CHW. Community Health Workers are people who have undergone several weeks of community outreach and health education training. During the study period the participant will continue to receive all of their regular medical care from their regular health care providers. If the participant does not have a health care provider, the Community Health Workers would be able to help in referring the participant for care at a local health care clinic located in their community.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
754
Inclusion Criteria
  1. live in one of the three target communities
  2. self-identify as Haitian, Hispanic and/or Black.
  3. be 50-64 years old
  4. need at least one of the four recommended screening services as per US Preventive Service Task Force 121 guidelines as follows: never having had a HIV test b) never having had a Hepatitis C Virus (HCV) test c) not having a Pap smear in the last three years d) not having had a colonoscopy in last 10 years and/or stool-based test in the last year.
Read More
Exclusion Criteria
  1. plan to move out of the community during the next six months;
  2. current or prior enrollment (5 five years) in any research study that involved screening for these conditions.
  3. Are adults unable to consent
  4. Are individuals who are not yet adults (infants, children, teenagers)
  5. Pregnant women
  6. Prisoners
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Home Based ScreeningOraQuick FingerstickThe participant will be receiving home-based screening tests (OraQuick Swab, OraQuick Fingerstick, Human Papillomavirus (HPV) Self-Sampling Test, Fecal Immunochemical Test) delivered by the community health worker
Home Based ScreeningOraQuick SwabThe participant will be receiving home-based screening tests (OraQuick Swab, OraQuick Fingerstick, Human Papillomavirus (HPV) Self-Sampling Test, Fecal Immunochemical Test) delivered by the community health worker
Home Based ScreeningFecal Immunochemical TestThe participant will be receiving home-based screening tests (OraQuick Swab, OraQuick Fingerstick, Human Papillomavirus (HPV) Self-Sampling Test, Fecal Immunochemical Test) delivered by the community health worker
Clinic Based ScreeningStandard Screening TestsThe participant will meet the Community Health Worker and will be navigated to a clinic appointment for standard screening tests
Home Based ScreeningHPV Self-Sampling TestThe participant will be receiving home-based screening tests (OraQuick Swab, OraQuick Fingerstick, Human Papillomavirus (HPV) Self-Sampling Test, Fecal Immunochemical Test) delivered by the community health worker
Home Based ScreeningHome Based Screening TestsThe participant will be receiving home-based screening tests (OraQuick Swab, OraQuick Fingerstick, Human Papillomavirus (HPV) Self-Sampling Test, Fecal Immunochemical Test) delivered by the community health worker
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Who Are Screened for All ConditionsBaseline

As evaluated by participant self report and completed sampling kits. Female participants are to be screened on 4 conditions: HIV, HCV, Human Papilloma Virus (HPV) and Fecal Immunochemical Testing (FIT). Male participants are to be screened on 3 conditions: HIV, Hepatitis C Virus (HCV) and FIT.

Secondary Outcome Measures
NameTimeMethod
Change in Percentage of Participants Completing Screening Test From Baseline to 6 MonthsBaseline, Up to 6 months

As evaluated by participant self report and completed sampling kits. Female participants are to be screened on 4 conditions: HIV, HCV, HPV and FIT. Male participants are to be screened on 3 conditions: HIV, HCV and FIT.

Median Number of Screenings CompletedAt baseline and at 6 months

As evaluated by participant self report and completed sampling kits. Female participants are to be screened on 4 conditions: HIV, HCV, HPV and FIT. Male participants are to be screened on 3 conditions: HIV, HCV and FIT.

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath